Mr. Kocmond joined us as Executive Vice President, Global Operations in May 2013. He was appointed Chief Operating Officer in October 2014 and President in February 2016, with responsibility for Global Commercial Operations, Manufacturing Operations and Engineering. Prior to joining Cepheid, Mr. Kocmond served as Vice President of Global Operations for Lam Research Corporation, where he was responsible for globally dispersed operations, including a multi-billion dollar supply chain. Prior to Lam Research, Mr. Kocmond was Executive Vice President of Global Operations and Quality at Verigy, Ltd., now a wholly owned subsidiary of Advantest Corp. Mr. Kocmond previously held operations and management positions at Applied Materials and Silicon Graphics, among other companies, and brings well over two decades of relevant experience to the Company.
Scott A. Campbell, Ph.D.
Corporate Vice President and Chief Regulatory Officer
Dr. Campbell joined Cepheid’s Clinical Affairs group in 2010 and has held several positions of increasing responsibility prior to his appointment as our Chief Regulatory Officer in August 2015. Prior to Cepheid, Dr. Campbell was Director of Clinical Affairs, and earlier, Director of Marketing for Nucleic Acids at Nanosphere from 2006-2010. From 2003-2006, Dr. Campbell was the Executive Director of Marketing at Third Wave Technologies (presently part of Hologic, Inc.), and from 2001-2003, Dr. Campbell held various technical support, marketing, and strategic product development roles at Vysis, Inc. (presently part of Abbott Molecular). Dr. Campbell earned his PhD in Cell, Molecular, and Developmental Biology from the University of California-Riverside (UCR) where he was a National Science Foundation Graduate Research Trainee, and earned his MBA concurrently.
Executive Vice President, Worldwide Commercial Operations
Mr. Farrell joined us in June 2014 from Abbott Point of Care, where he served as the Vice President and General Manager of commercial operations, with responsibilities for the global sales and marketing, strategic business development and program management. Prior to Abbott Point of Care, Mr. Farrell spent six years at iCAD and CADx, as the Executive Vice President of Global Operations, with responsibilities for all aspects of the breast imaging business. Mr. Farrell started his career with Abbott Diagnostics in various leadership roles in the commercial organization for 10 years.
Executive Vice President, Global Operations and Engineering
Mr. Haugen joined us as Executive Vice President of Engineering and Operations in March 2016. Prior to joining Cepheid, Mr. Haugen was most recently Group Vice President of Worldwide Operations and Supply Chain at Applied Materials, where he was responsible for a global employee team and factories across eight countries and an annual multi-billion dollar supply chain. Mr. Haugen previously spent 15 years at Lam Research, where he held numerous positions in Product and Business Operations, including Corporate Vice President of Global Product Operations. Prior to Lam Research, Mr. Haugen worked at Applied Materials from 1991 to 1998, where he served in Product Management, Business Process, Manufacturing Engineering, and Business Operations roles. Mr. Haugen began his career as a Surface Warfare Officer in the U.S. Navy in 1987.
Daniel E. Madden
Executive Vice President, Chief Financial Officer
Mr. Madden joined us as Vice President and Corporate Controller in June 2014, and was named Executive Vice President and Chief Financial Officer in August 2015 following a period as Acting Chief Financial Officer from February 2015 to April 2015. Prior to joining us, Mr. Madden served in senior financial roles including Vice President, Finance and Corporate Controller, and Vice President, Finance and Investor Relations, at Symmetricom, Inc., which was acquired by Microsemi Corporation, in addition to other senior financial positions at Sonic Solutions, Tellabs, Advanced Fibre Communications, and McKesson. Mr. Madden began his career with Ernst & Young and is a Certified Public Accountant (Inactive).
William E. Murray, J.D.
Executive Vice President, General Counsel and Chief Privacy Officer
Mr. Murray joined us in October 2010 as Vice President, IP - Oncology, responsible for Cepheid's cancer diagnostics business development and worldwide commercial legal support. He was appointed Chief Privacy Officer in 2013 and Executive Vice President, General Counsel in January 2016. From 2002 to 2010, Mr. Murray was Division Counsel, Abbott Laboratories, responsible at various times for non-litigation patent matters for Abbott Diagnostics, Abbott Molecular and Abbott Point of Care. Prior to Abbott, Mr. Murray served as Vice President, General Counsel and Secretary of Vysis, Inc. from 1994 to 2001. Mr. Murray began his legal career with Amoco Corporation in 1983. He holds a J.D. from the University of Tulsa, and a B.A. in Chemistry from Vanderbilt University.
David H. Persing, M.D., Ph.D.
Executive Vice President, Chief Medical & Technology Officer
Dr. Persing first joined Cepheid as a director in May 2004, and became our Executive Vice President and Chief Medical and Technology Officer in August 2005. From 1999 to 2005, Dr. Persing was a research executive and Chief Scientific Officer at Corixa Corporation, a Seattle-based biotechnology company, until its acquisition by GlaxoSmithKline. Prior to that he was a member of the Clinical and Research Faculty of the Mayo Clinic in Rochester, Minnesota where he directed clinical laboratories and conducted extramurally funded research on infectious diseases. In 1992 he founded and directed the Molecular Microbiology Laboratory at Mayo Clinic. He has authored over 270 peer-reviewed articles, many of which are in high impact journals, and served as Editor-in-Chief for five textbooks on Molecular Diagnostics, the most recent of which was published by ASM press in 2016.